25 May 2013
Keywords: schein, market, generic, habitrol, usa, pharmaceutical, elan
Article | 04 November 1999
Schein Pharmaceutical will market Elan Corp's Nicotine TransdermalSystem USP in the USA. The product is a generic version of Novartis'
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 November 1999
3 November 1999
24 May 2013
© 2013 thepharmaletter.com